NCT04024722

Brief Summary

Improving the results of in vitro fertilization in women with poor ovarian response and early ovarian insufficiency

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 18, 2019

Completed
6 months until next milestone

Study Start

First participant enrolled

January 14, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

July 28, 2021

Status Verified

July 1, 2021

Enrollment Period

1.5 years

First QC Date

July 3, 2019

Last Update Submit

July 27, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Number of oocytes

    Number of oocytes

    up to 1 year

  • Fertilization rate

    Fertilization rate

    up to 1 year

  • Embryos number

    Embryos number

    up to 1 year

  • Pregnancies rate

    Pregnancies rate

    up to 1 year

Study Arms (2)

Single ovary treatment

EXPERIMENTAL
Procedure: In Vitro Fertilization

Dual ovary treatment

EXPERIMENTAL
Procedure: In Vitro Fertilization

Interventions

Patients suitable for research with poor ovarian response will receive treatment including laparoscopic surgery, resection, and transplantation of ovarian tissue in the same operation to improve the chances of success of in vitro fertilization and pregnancy. Participants will be assessed for surgical incisions and fertility assessment up to two weeks after treatment, including general physical examination, US pelvic examination, and blood tests for a hormonal profile to determine the initiation of ovarian stimulation and IVF. Patients will be monitored from 2 weeks to 1 year after treatment (once a week in the first two months and one month for one year after surgery), which will include a general physical examination, a US test, and blood tests for the hormonal profile at the IVF clinic.

Dual ovary treatmentSingle ovary treatment

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Volunteers with poor ovarian response to standard fertility treatments according to the criteria of the European Fertility Association (ESHRE).
  • Diagnosis of early ovarian insufficiency or symptoms that predict early ovarian insufficiency (imminent) seeking to become pregnant.

You may not qualify if:

  • Volunteers with
  • Severe endometriosis diagnosed with laparoscopy.
  • Previous major surgery involving ovaries.
  • Ovarian cancer.
  • Female reproductive malformations.
  • Contraindications for laparoscopic surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barzilay University Medical Center

Ashkelon, Israel

RECRUITING

Related Publications (1)

  • Grin L, Berkovitz-Shperling R, Goldstein G, Michailov Y, Gemer O, Anteby E, Kawamura K, Saar-Ryss B, Friedler S. Drug-free in vitro activation of ovarian follicles and fresh tissue autotransplantation in patients with poor ovarian response and premature ovarian insufficiency. F S Sci. 2025 Aug;6(3):303-311. doi: 10.1016/j.xfss.2025.04.002. Epub 2025 Apr 30.

MeSH Terms

Interventions

Fertilization in Vitro

Intervention Hierarchy (Ancestors)

Reproductive Techniques, AssistedReproductive TechniquesTherapeuticsInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of IVF unit

Study Record Dates

First Submitted

July 3, 2019

First Posted

July 18, 2019

Study Start

January 14, 2020

Primary Completion

July 31, 2021

Study Completion

July 31, 2022

Last Updated

July 28, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations